<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(4)</volume><submitter>Zhao Q</submitter><funding>funding</funding><pubmed_abstract>Hepatocellular carcinoma (HCC) is responsible for high morbidity and mortality worldwide. Increasing evidence suggests that microRNAs intensively participate in HCC development and progression. In the current study, we aimed to explore the impact of miR-124-3p in the proliferation and epithelial-mesenchymal transition (EMT) of HCC. The RT-qPCR assay was employed to determine miR-124-3p expression in human HCC specimens and cell lines. Luciferase assay was used to validate the miR-124-3p target gene. Western Blot and RT-qPCR were performed to study the effects of miR-124-3p modulation on ARRDC1 (Arrestin Domain Containing 1) mRNA and protein expressions. MTT assay, wound healing assay, EdU assay, and Transwell assay were utilized to verify the impact of miR-144-3p modulation on HCC prolifer</pubmed_abstract><journal>Bioengineered</journal><pagination>8255-8265</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9161870</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>MicroRNA miR-124-3p suppresses proliferation and epithelial-mesenchymal transition of hepatocellular carcinoma via ARRDC1 (arrestin domain containing 1).</pubmed_title><pmcid>PMC9161870</pmcid><pubmed_authors>Zhang F</pubmed_authors><pubmed_authors>Jiang F</pubmed_authors><pubmed_authors>Zhao Q</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Zhuang H</pubmed_authors><pubmed_authors>Chu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>MicroRNA miR-124-3p suppresses proliferation and epithelial-mesenchymal transition of hepatocellular carcinoma via ARRDC1 (arrestin domain containing 1).</name><description>Hepatocellular carcinoma (HCC) is responsible for high morbidity and mortality worldwide. Increasing evidence suggests that microRNAs intensively participate in HCC development and progression. In the current study, we aimed to explore the impact of miR-124-3p in the proliferation and epithelial-mesenchymal transition (EMT) of HCC. The RT-qPCR assay was employed to determine miR-124-3p expression in human HCC specimens and cell lines. Luciferase assay was used to validate the miR-124-3p target gene. Western Blot and RT-qPCR were performed to study the effects of miR-124-3p modulation on ARRDC1 (Arrestin Domain Containing 1) mRNA and protein expressions. MTT assay, wound healing assay, EdU assay, and Transwell assay were utilized to verify the impact of miR-144-3p modulation on HCC prolifer</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-05-29T20:26:37.712Z</modification><creation>2025-02-19T03:21:54.725Z</creation></dates><accession>S-EPMC9161870</accession><cross_references><pubmed>35300565</pubmed><doi>10.1080/21655979.2022.2051686</doi></cross_references></HashMap>